Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV: Clinical Trial (HIV)
| Sponsor: | NIAAA NIH |
| Enrolling: | Male and Female Patients |
| Study Length: | 90 Days |
| Clinic Visits: | 5 |
| Age Range: | Between 18 and 99 years old |
| IRB Number: | 7649 |
| U.S. Government ID: | NCT03652675 |
| Contact: | Jennifer Elliott, PhD: 646-774-7953 / jce2130@cumc.columbia.edu |
For individuals who have both HIV and Hepatitis C virus (HCV), heavy drinking poses serious risks to their health. We do not yet know which interventions are effective at helping individuals with HIV and HCV drink less. The goal of the study is to compare two different interventions to find out if they help patients drink less. Patients who are eligible will be randomized to one of two conditions. One group will receive in-person meetings with a counselor and will use a smartphone app to track their drinking over two months. The other group will receive educational materials and advice to decrease drinking. Participants will complete five appointments (a screening, three study appointments with a counselor, and a follow-up survey) over three months. Participants will be compensated up to $230 for full participation in the study.
| Are you between 18 and 99 years of age? | Yes | No |
| Are you currently living with HIV? | Yes | No |
| Have you ever been informed that you have Hepatitis C virus (HCV) (regardless of whether you have ever gotten treatment for it)? | Yes | No |
| Can you speak and read in English? | Yes | No |
| Do you have an HIV care provider that you see regularly in the NY metro area? | Yes | No |
